← 產業報告目錄

Gene Panel Market, By Technique (Amplicon-Based, Hybridization-Based), By Design (Predesigned Gene Panels, Customized Gene Panels), By Application (Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, Others), By End User (Research and Academic Institutes, Hospital and Diagnostic Laboratories, Biotechnology and Pharmaceutical Companies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版商 Coherent Market Insights出版日期 2026-07-09頁數 259報告編號 CMR-be72bde01e

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible. Market Dynamics Market players are conducting clinical trials for exploring the potential uses of gene panels for diagnosis of a number of genetic disorders, which could contribute to the growth of the gene panel market over the forecast period. For instance, in November 2020 Bordeaux University Hospital, France, initiated an observational clinical study for implementation of a next generation sequencing gene panel for diagnosis of incomplete forms of albinism. This study identifies the usability of NGS gene panel in overcoming the challenges faced in identification of ocular albinism as it does not show many observable ophthalmic signs. This study comprises of 100 participants and is expected to be completed by March 2022. Market players are focusing on launch of products, which is expected to strengthen their position in the global gene panel market. For instance, in June 2018, Thermo Fisher Scientific Inc., an American scientific instrumentation company, launched Ion AmpliSeq HD technology as an amplicon-based library for targeted next gene sequencing, it enables the user to customize one’s own gene panel by selecting the appropriate gene sequences from the gene library which are associated with a particular disease and detect low-frequency alleles in tumor RNA or DNA. Key features of the study • This report provides an in-depth analysis of global gene panel market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players • It profiles leading players in the global gene panel market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics • The global gene panel market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the gene panel market Market Segmentation • By Technique Insights (Revenue, USD Mn, 2021 - 2033) o Amplicon-Based o Hybridization-Based • By Design Insights (Revenue, USD Mn, 2021 - 2033) o Predesigned Gene Panels o Customized Gene Panels • By Application Insights (Revenue, USD Mn, 2021 - 2033) o Pharmacogenetics o Diagnosis of Congenital Disorders o Cancer Risk Assessment o Others • By End User Insights (Revenue, USD Mn, 2021 - 2033) o Research and Academic Institutes o Hospital and Diagnostic Laboratories o Biotechnology and Pharmaceutical Companies • By Region Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players in the Gene Panel Market o Thermo Fisher Scientific Inc. o BGI o GENEWIZ, Inc. o GATC Biotech o Novogene Co., Ltd. o QIAGEN o Integrated DNA Technologies, Inc. o Illumina Inc. o Agilent Technologies, Inc. o Eurofins Scientific o Hoffmann-La Roche Ltd o Personalis Inc. o GeneDx Inc. o Invitae Corporation.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Technique  Market Snippet, By Design  Market Snippet, By Application  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Porter’s Analysis o Industry Trends o Pipeline Analysis o Key Highlights o Epidemiology o Pricing Analysis o Reimbursement Scenario o Regulatory Scenario o Global Supply Chain Analysis 4. Global Gene Panel Market, By Technique, 2021-2033 (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Amplicon-Based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Hybridization-Based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) 5. Global Gene Panel Market, By Design, 2021 - 2033 (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Predesigned Gene Panels  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Customized Gene Panels  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) 6. Global Gene Panel Market, By Application, 2021 - 2033 (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pharmacogenetics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Diagnosis of Congenital Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Cancer Risk Assessment  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) 7. Global Gene Panel Market, By End User, 2021 - 2033 (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Research and Academic Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Hospital and Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) o Biotechnology and Pharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million) 8. Global Gene Panel Market, By Region, 2021 - 2033 (USD Million) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022 - 2033  Regional Trends o North America  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033 (USD Mn) o U.S. o Canada o Latin America  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033 (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033 (USD Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033 (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033 (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Technique, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Design, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033 (USD Mn) o South Africa o Central Africa o North Africa 9. Competitive Landscape o Company Profiles  Thermo Fisher Scientific Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  BGI o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  GENEWIZ, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  GATC Biotech o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Novogene Co., Ltd. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  QIAGEN o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Integrated DNA Technologies, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Illumina, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Agilent Technologies, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Eurofins Scientific o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Hoffmann-La Roche Ltd o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Personalis Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  GeneDx Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Invitae Corporation o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies o Analyst Views 10. Section o References o Research Methodology o About us and Sales Contact
圖表清單 List of Tables & Figures
NA NA

提及公司

o Thermo Fisher Scientific Inc.o BGIo GENEWIZInc.o GATC Biotecho Novogene Co.Ltd.o QIAGENo Integrated DNA TechnologiesInc.o Illumina Inc.o Agilent TechnologiesInc.o Eurofins Scientifico Hoffmann-La Roche Ltdo Personalis Inc.o GeneDx Inc.o Invitae Corporation.

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們